Skip to main content

Table 2 Univariate and multivariate analyses for survival

From: Combined neutrophil-lymphocyte ratio and platelet-lymphocyte ratio predicts chemotherapy response and prognosis in patients with advanced gastric cancer

Independent factor

Univariate analysis

Multivariate analysis

Hazard ratio

95% CI

p value

Hazard ratio

95% CI

p value

Sex

  

0.7321

   

 Female

1.000

reference

    

 Male

1.066

0.742–1.557

    

Age (years)

  

0.2095

   

  < 70

1.000

reference

    

  ≥ 70

1.257

0.878–1.786

    

Therapeutic type

 

0.0227

  

0.1226

 Chemoradiotherapy

1.000

reference

 

1.000

reference

 

 Chemotherapy

5.369

1.199–94.547

 

3.499

0.770–61.865

 

Tumor response

 

<  0.0001

  

<  0.0001

 Non-PD

1.000

reference

 

1.000

reference

 

 PD

5.145

3.523–7.522

 

4.226

2.834–6.328

 

NLR-PLR score

 

< 0.0001

  

0.0392

 0

1.000

reference

 

1.000

reference

 

 1

1.923

1.259–2.991

0.0023

1.363

0.875–2.157

0.1726

 2

3.296

2.027–5.390

< 0.0001

1.958

1.167–3.299

0.0110

  1. CI confidence interval, NLR neutrophil–lymphocyte ratio, PD progressive disease, PLR platelet–lymphocyte ratio
Back to article page

BMC Cancer

ISSN: 1471-2407

Contact us